ANGELALIGN TECHNOLOGY INC. is one of the leading clear aligner processing solution providers in China.
Shanghai, China, 06 Jul. 2022 (GLOBE NEWSWIRE) — On June 23, ANGELALIGN TECHNOLOGY INC. Received the “Most Honored Company” award in the 2022 All-Asia Executive Team Institutional Investor Survey. Ranked second overall in the Healthcare and Pharmaceuticals category, the company took second place in four other individual awards, namely “Best CEO”, “Best IR Professional”, “IR Program” and “ESG”.
This year, a total of 1,612 listed companies across 18 sectors were nominated in the Institutional Investor 2022 All-Asia management team poll. Although this is the first time that ANGELALIGN TECHNOLOGY INC. been noted in the survey since its listing on the Hong Kong Stock Exchange in June 2021, the company has received various awards from the Institutional Investor, which highlights the high recognition of the capital market on ANGELALIGN TECHNOLOGY INC. in corporate governance and investor relations, etc.
ANGELALIGN TECHNOLOGY INC. is one of the leading clear aligner processing solution providers in China. Since its inception, the company has immersed itself in “digital orthodontics” focusing on the needs of dental professionals and clinical scenarios. It has developed proprietary and industry-leading technological capabilities in five disciplinary areas including clinical stomatology, biomechanics, materials science, computer science and smart manufacturing technology. With the help of continuously refined technology products and services, the company has empowered physicians to act holistically. Facing a series of challenges related to COVID-19 and low consumption, etc. over the past year, ANGELALIGN TECHNOLOGY INC. maintained an agile forecast in the market and quickly applied adaptive strategies to best seize opportunities while focusing on the long-term growth of the business. . The company completed approximately 183,200 case shipments, served approximately 25,000 dental professionals throughout the year, achieving high-quality growth and breakthroughs, and further solidifying its leading position in China’s clear aligner market. According to the China Insights Consultancy report, measured by case shipments delivered in 2021, ANGELALIGN TECHNOLOGY INC. garnered the highest market share of 41.1% in China’s clear aligner industry.
ANGELALIGN TECHNOLOGY INC. Wins Multiple Awards in Institutional Investor Magazine’s 2022 All-Asia Leadership Team
Institutional Investor is one of the most influential financial magazines for global investment institutions and has enjoyed high credibility since being published for over 50 years. The magazine conducts an annual survey of the management teams of listed companies around the world. Only certified financial professionals have the right to vote, which makes the institutional investor ranking one of the most authoritative rankings in the capital market, and its ranking results become a global investment pioneer, recognized by buy-side investors and sell-side institutions.
This year, 4,854 buy-side professionals and 670 sell-side analysts took part in this survey. Among them, the number of voters increased by 35% compared to 2021, reaching an all-time high, with about 2 trillion dollars in Asian stocks (excluding Japan). The nominated listed companies were rated in several key areas as below:
1. Service & Communications
Business and market knowledge
Authority and credibility of the IR team
2. Financial Disclosure
Time to market (speed)
4. Chief Financial Officer
5. Professional IR
ANGELALIGN TECHNOLOGY INC. is committed to helping doctors achieve stable, easy, timely and accurate diagnosis and treatment through technological products and services based on digital technologies, and providing people with healthy, straightened teeth and brighter smiles dazzling. ANGELALIGN TECHNOLOGY INC. specializing in digital dentistry, wants to work with doctors to generate cutting-edge innovations based on clinical feedback from doctors and patient needs. Additionally, with continuous innovation and evolution efforts, the company leverages its interdisciplinary R&D capabilities – it has built reliable technology and data platforms to provide more targeted and reliable solutions for complex cases. of malocclusion. At the same time, ANGELALIGN TECHNOLOGY INC. effectively implements corporate governance based on international standards and has a hard-working, far-sighted and experienced management team.
As “China’s Leading Orthodontic Stock”, ANGELALIGN TECHNOLOGY INC. has a management team that continues to take a proactive and holistic attitude, firmly adheres to the “Customer First” principle, and upholds the mission of “Using Technology to Create Brighter Smiles Influencing the World”. Under the dual impetus of medical science as its essence and technological innovation as its objective, the Company will fully exploit its fundamental strengths to energize the upstream and downstream of the industrial chain and break the existing technological shackles. barriers, meanwhile, is committed to remaining the pioneer in the field of digital orthodontics in China and promoting the growth, transformation and sustainable development of the digital orthodontics ecosystem in China.
Company: ANGELALIGN TECHNOLOGY INC.
Contact: Jewel Huo
E-mail: [email protected]
Tel: (86) 21-56561919